Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -0.20 is in line with its 5-year average of -0.21, around the middle of its 5-year range (-2.26–1.29).
As of the fiscal period ended Wednesday, December 31, 2025. 251.26% below its 12-month average of -0.06.
Reported quarterly debt to equity ratio; no daily interpolation. Q4 FY2025 (2025-12-31): -0.20.
DEBT TO EQUITY RATIO
-0.20
DEBT TO EQUITY RATIO AVG TTM
-0.06
DEBT TO EQUITY RATIO AVG 3Y
0.03
DEBT TO EQUITY RATIO AVG 5Y
-0.21
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-251.26%
CURRENT VS 3Y AVG
-894.30%
CURRENT VS 5Y AVG
+4.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13
median of 568 covered companies
CURRENT VS SECTOR MEDIAN
-255.15%
vs the sector median at left
Apollomics, Inc.
Market Cap
$49.15M
Debt to Equity Ratio
-0.20
TTM Avg
-0.06
3Y Avg
0.03
5Y Avg
-0.21
Market Cap
$48.76M
Debt to Equity Ratio
0.01
TTM Avg
0.02
3Y Avg
0.04
5Y Avg
0.04
Market Cap
$48.32M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.13
5Y Avg
0.14
Market Cap
$51.05M
Debt to Equity Ratio
0.05
TTM Avg
0.11
3Y Avg
0.11
5Y Avg
0.11
Market Cap
$51.33M
Debt to Equity Ratio
0.25
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$52.54M
Debt to Equity Ratio
0.00
TTM Avg
0.89
3Y Avg
0.55
5Y Avg
0.44
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apollomics, Inc. (APLM) | $49.15M | -0.20 | -0.06 | 0.03 | -0.21 |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | 0.01 | 0.02 | 0.04 | 0.04 |
| Clene Inc. (CLNN)vs › | $49.68M | N/A | 6.12 | 6.71 | 4.67 |
| Lite Strategy, Inc. (LITS)vs › | $48.32M | 0.00 | 0.00 | 0.13 | 0.14 |
| Celularity Inc. (CELU)vs › | $49.93M | N/A | 4.70 | 2.51 | 1.98 |
| INmune Bio, Inc. (INMB)vs › | $51.01M | 0.07 | 0.03 | 0.14 | 0.13 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.05M | 0.05 | 0.11 | 0.11 | 0.11 |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | 0.25 | 0.00 | 0.00 | 0.00 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.54M | 0.00 | 0.89 | 0.55 | 0.44 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.13M | 0.00 | 0.12 | 0.06 | 0.04 |
Debt/Equity
-0.20
Current Ratio
0.96
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2025-12-31 | -0.20 |
| 2025-06-30 | -0.17 |
| 2024-12-31 | 0.20 |
| 2024-06-30 | 0.23 |
| 2023-12-31 | 0.11 |
| 2023-06-30 | 0.01 |
| 2022-12-31 | 0.00 |
| 2022-06-30 | -0.01 |
| 2021-12-31 | -1.53 |
| 2021-06-30 | 1.29 |
| 2020-12-31 | -2.26 |
| 2020-06-30 | 0.00 |
| 2019-12-31 | -2.24 |
| 2019-06-30 | 0.00 |
